Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 199,163 | 104,514 | 135,381 | 116,657 | 142,712 |
| Marketable Securities | 349,723 | 357,754 | 352,164 | 432,972 | 484,193 |
| Receivables | 1,371 | 812 | 1,097 | 8,649 | 1,469 |
| TOTAL | $560,649 | $480,137 | $500,252 | $565,537 | $635,264 |
| Non-Current Assets | |||||
| PPE Net | 8,721 | 8,887 | 9,205 | 9,696 | 10,278 |
| Investments And Advances | 37,152 | 92,988 | 137,297 | 141,498 | 127,496 |
| Other Non-Current Assets | 26,641 | 25,824 | 27,527 | 26,549 | 25,101 |
| TOTAL | $72,514 | $127,699 | $174,029 | $177,743 | $162,875 |
| Total Assets | $633,163 | $607,836 | $674,281 | $743,280 | $798,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40,260 | 36,840 | 31,588 | 30,648 | 34,221 |
| TOTAL | $41,792 | $38,335 | $33,047 | $32,030 | $35,590 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9,611 | 9,990 | 7,256 | 7,293 | 7,646 |
| TOTAL | $9,611 | $9,990 | $7,256 | $7,293 | $7,646 |
| Total Liabilities | $51,403 | $48,325 | $40,303 | $39,323 | $43,236 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,190 | 77,275 | 77,106 | 76,734 | 76,543 |
| Common Shares | 1,598,571 | 1,475,371 | 1,469,196 | 1,460,850 | 1,456,836 |
| Retained earnings | -1,245,380 | -1,140,119 | -1,049,223 | -964,517 | -899,470 |
| Other shareholders' equity | 335 | 477 | 113 | -836 | -1,612 |
| TOTAL | $581,760 | $559,511 | $633,978 | $703,957 | $754,903 |
| Total Liabilities And Equity | $633,163 | $607,836 | $674,281 | $743,280 | $798,139 |